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ed.2012.Abstract Endobronchial carcinoid tumor is an extremely rare neoplasm in children and adoles-
cence. Herein, a case of endobronchial carcinoid tumor in a 15 year old female presented with recur-
rent chest infection for a long time and after a careful examination and investigation, the case was
diagnosed.
ª 2012 Taibah University. Production and hosting by Elsevier Ltd. All rights reserved.Introduction
Bronchial carcinoid tumors are extremely rare in children, and
represent a rare cause of pulmonary obstruction. Because of
low clinical suspicion and various ways of presentation, diag-
nosis may be delayed.1 In the recent classiﬁcation of lung tu-
mors by the World Health Organization (WHO) and the
International Association for the Study of Lung Cancer (IAS-
LC), bronchial carcinoids have been considered as a part of the
neuroendocrine tumor spectrum (typical carcinoid, atypical
carcinoid, large cell neuroendocrine carcinoma, and small cell
carcinoma), and typical and atypical carcinoids have been
grouped together because they are more closely related clini-
cally than other neuroendocrine tumors and share similar bio-
logic markers.2hroacic Surgery, King Fahad
Kingdom of Saudi Arabia.
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A female patient aged 15 years old with no signiﬁcant past
medical history came complaining of fever with productive
cough and a mild chest pain on right side for a month. She
was treated for recurrent chest infection for 7 months which
was persistent. On presentation, chest examination showed
decreased air entry in the right lower side of her chest. Chest
X-ray and Computerised tomography scan of the chest
(CT-scan) were carried out. Chest X-ray (Figure 1) showed
total collapse of the right lower lobe and consolidation of
the middle lobe with multiple cavities. CT-scan chest (Figure
2) showed right bronchial mass extending from the right lower
lobe bronchus obstructing it. Bronchoscopy (Figure 3) revealed
vascular mass arising from the right lower lobe bronchus and
extended to obstruct the right middle lobe bronchus. A biopsy
was taken to conﬁrme the diagnosis of the suspected carcinoid
tumor. The patient underwent right posterolateral thoracot-
omy where a total collapse of the middle and lower lobes
was found. So, bilobectomy (middle and lower lobes) was done
and a lymph node was taken for a biopsy. Histopathology of
the specimens (tumor, middle and lower lobes, lymph node)
showed a typical endobronchial carcinoid tumor with no
lymph node metastasis and a free resection margin. Post
operative course of the patient was unremarkable (Figure 4).Ltd. All rights reserved.
Figure 1: Chest X-ray showing collapsed Rt. Lower lobe and
consolidation of the middle lobe with multiple cavities.
Figure 2: Bronchial mass extending from right lower lobe
bronchus obstructing it.
Figure 3: Vascular mass arising from right lower lobe bronchus.
Figure 4: Post-operative inﬂation of the Rt. Upper lobe.
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Bronchial carcinoid is a neuroendocrine neoplasm deriving
from neuroendocrine cells of the bronchial and bronchiolar
epithelium.3 Carcinoid tumors occur most frequently in the
gastrointestinal tract (90% of cases). The second most com-
mon site of occurrence is the respiratory tract. Carcinoid tu-
mors are relatively uncommon pulmonary neoplasm
comprising only approximately 1–2% of cases.3Histologically, carcinoid tumors can be characterized as
low-grade or typical carcinoid, intermediate grade or atypical
carcinoid, and high-grade large-cell and small-cell neuroendo-
crine tumors. All bronchial carcinoids are considered malig-
nant and have the potential to metastasize.4 The mean age of
presentation of carcinoid tumors of the bronchial tree is
45 years.3 Atypical carcinoids tend to present approximately
one decade later than low-grade/typical carcinoids. Endobron-
chial neoplasms are extremely rare in children. The most com-
mon endobronchial neoplasm in children is the carcinoid
tumor, but the majority of these cases are present during ado-
lescence because of the delay in diagnosis.4 The majority of
pulmonary carcinoids in the pediatric population are present
with symptoms. The most common presenting manifestations
are wheezing, atelectasis, or pneumonia.5 Other presenting
symptoms include cough, chest pain, and hemoptysis. As in
our patient, endobronchial carcinoid is commonly not consid-
ered until the patient’s symptoms and radiographic abnormal-
ities persist or recur after appropriate therapy. According to
the study of Wang et al.5, the average duration of symptoms
in affected children prior to diagnosis is 8.5 months.
Bronchoscopy plays a big role in the diagnosis of carcinoids
in the majority of cases because the tumor is centrally located
and visible at endoscopic evaluation.6 Some authors found
bleeding to occur in two thirds of their patients and some ad-
vice against a biopsy when carcinoid is suspected; other
authors disagreed, maintaining that a bronchoscopic biopsy
signiﬁcantly increases the diagnostic yield without adding mor-
bidity.6 In this case, no troublesome bleeding was reported
after endoscopic biopsy.
The imaging features of the carcinoid tumors are dependent
upon the location of the lesion. Approximately 80% of pul-
monary carcinoids occur centrally in the main, lobar, or seg-
mental bronchi; the single most common radiographic
presentation of a carcinoid tumor is that of a hilar or perihilar
mass with associated atelectasis and/or inﬁltrate.7 On radiog-
raphy, the central lesion can sometimes be obscured and the
ﬁndings are limited to the lesion’s post-obstructive sequelae.
On both, radiography and conventional CT, the mass is usu-
ally well-deﬁned, round, and sometimes slightly lobulated.
Approximately, 30% of the carcinoid tumors exhibit histolog-
ical evidence of calciﬁcation that can be seen in a CT and help
in narrowing the differential diagnosis.8 Some endobronchial
carcinoids have extensive intrapulmonary components, a ﬁnd-
ing that is readily identiﬁed by a CT. Some lesions are noted to
112 Endobronchial carcinoid tumor in a 15 years old patienthave a ball-valve effect that contributes to lobar or semilobar
hyperinﬂation.
Because all carcinoid tumors have the potential to metasta-
size, the deﬁnitive treatment is surgical resection. Depending
on the tumor size, histological grade, and endobronchial vs.
intrapulmonary extent, surgical approaches can range from
total pneumonectomy to more conservative techniques such
as sleeve bronchectomy. The prognosis for typical carcinoid
is good with an overall survival rate of 5 and 10 years is
92% and 88% respectively.9 Atypical carcinoids have a poor
prognosis.
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